Equities

Japan Tissue Engineering Co Ltd

7774:TYO

Japan Tissue Engineering Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)495.00
  • Today's Change1.00 / 0.20%
  • Shares traded13.10k
  • 1 Year change-3.51%
  • Beta1.2314
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4,2664,1354,933
Total Receivables, Net609576496
Total Inventory229238187
Prepaid expenses323276
Other current assets, total204231252
Total current assets5,3395,2115,946
Property, plant & equipment, net1,5111,5671,614
Goodwill, net------
Intangibles, net1039436
Long term investments0.020.020.02
Note receivable - long term------
Other long term assets1.902.082.18
Total assets6,9896,8837,598
LIABILITIES
Accounts payable84136117
Accrued expenses181152152
Notes payable/short-term debt000
Current portion long-term debt/capital leases00.130.80
Other current liabilities, total609623627
Total current liabilities874911897
Total long term debt000.13
Total debt00.130.94
Deferred income tax------
Minority interest------
Other liabilities, total353535
Total liabilities908946932
SHAREHOLDERS EQUITY
Common stock4,9594,9594,959
Additional paid-in capital2,7892,7892,789
Retained earnings (accumulated deficit)(1667)(1810)(1081)
Treasury stock - common(0.31)(0.31)(0.31)
Unrealized gain (loss)------
Other equity, total0.000.000.00
Total equity6,0805,9376,666
Total liabilities & shareholders' equity6,9896,8837,598
Total common shares outstanding414141
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.